EZH2 expression was found to decrease in response to BRN2 siRNA knockdown in all three melanoma cell lines, reduced to levels of 0.4 fold or lower across all three lines tested compared to the negative siRNA control cells (Fig. 2A). This evidence concerns the gene POU3F2 and melanoma.